Investors & Media

Transformative science, targeted medicines

We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.

SEC Filings

SEC Filings

Filing date	Form	Description	View
Jan 17, 2014	D		View HTML 0001597264-14-000001.pdf 0001597264-14-000001.rtf 0001597264-14-000001.xls
Nov 20, 2014	D		View HTML 0001597264-14-000002.pdf 0001597264-14-000002.rtf 0001597264-14-000002.xls
May 07, 2015	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0000315066-15-002589.pdf 0000315066-15-002589.rtf
May 08, 2015	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001144204-15-028799.pdf 0001144204-15-028799.rtf 0001144204-15-028799.xls
May 08, 2015	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0000921895-15-001225.pdf 0000921895-15-001225.rtf 0000921895-15-001225.xls
Feb 10, 2016	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001193125-16-457617.pdf 0001193125-16-457617.rtf 0001193125-16-457617.xls
Mar 28, 2016	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001144204-16-090608.pdf 0001144204-16-090608.rtf 0001144204-16-090608.xls
Oct 25, 2016	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001193805-16-004164.pdf 0001193805-16-004164.rtf 0001193805-16-004164.xls
Dec 15, 2016	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001193805-16-004377.pdf 0001193805-16-004377.rtf 0001193805-16-004377.xls
Jan 30, 2017	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0000215457-17-002178.pdf 0000215457-17-002178.rtf

Continue